Table 2. Screening performance of invasive fungal infection based on data from different prospective studies.
| Author/year | Reference standard | True positive | False negative | False positive | True negative |
|---|---|---|---|---|---|
| Kawazu/2004 | EORTC/MSG | 6 | 7 | 2 | 134 |
| Horiguchi/2004 | EORTC/MSG | 7 | 1 | 9 | 52 |
| Pazos/2005 | EORTC/MSG | 7 | 1 | 3 | 26 |
| Akamatsu/2007 | EORTC/MSG | 14 | 10 | 26 | 130 |
| Senn/2008 | EORTC/MSG | 30 | 30 | 12 | 101 |
| Hachem/2009 | EORTC/MSG | 37 | 21 | 2 | 18 |
| Zhao/2009 | EORTC/MSG | 18 | 4 | 19 | 89 |
| Acosta/2011 | EORTC/MSG | 11 | 2 | 7 | 31 |
| Posteraro/2011 | EORTC/MSG | 15 | 1 | 5 | 74 |
| Mohr/2011 | EORTC/MSG | 14 | 1 | 14 | 28 |
| Bono/2011 | EORTC/MSG | 79 | 21 | 9 | 43 |